Evaluating Ubrogepant-related adverse events using the FDA adverse event reporting system-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluating Ubrogepant-related adverse events using the FDA adverse event reporting system

Published:2023-08-24 Issue: Volume: Page:1-7
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Cao Bing¹,Gu Shanshan¹,Shen Zhisen¹,Zhang Yuna¹,Shen Yiming²,Chen Hang³

Affiliation:

1. Department of Otorhinolaryngology Head and Neck Surgery, Lihuili Hospital affiliated to Ningbo University, Ningbo, Zhejiang, China

2. Department of Otology and Skull Base Surgery, National Health Commission Key Laboratory of Hearing Medicine (Fudan University), Shanghai City, P. R. China

3. Department of Thoracic surgery, The Affiliated Lihuili Hospital, Ningbo University, Ningbo, Zhejiang Province, P. R. China

Funder

Ningbo Clinical Research Center for Otolaryngology-Head and Neck Disease

Ningbo medical and health brand discipline

Ningbo Natural Science Foundation

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2251390

Reference31 articles.

1. Migraine

2. Diagnosis and Management of Headache

3. Migraine

4. Pharmacological treatment of migraine: Drug classes, mechanisms of action, clinical trials and new treatments

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-seizure medications-associated bladder and urethral symptoms: a pharmacovigilance analysis based on the FAERS database;Expert Opinion on Drug Safety;2024-06-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP